The former inhibits SLC7A11 transcription and assembly of the xc‐system by activating the Janus kinase/signal transducer and activator of transcription 1 (JAK/STAT1) pathway, which causes problems in the tumour antioxidant system.109. Here, STAT1 is linked to neoplasm.